Mirum Pharmaceuticals
$40.7
21
-$0.83-2% Friday 20:00
Statistik
Harga Tertinggi Hari
41.6
Harga Terendah Hari
40.51
52M Tertinggi
44.94
52M Terendah
23.14
Volum
454,215
Volum Purata
641,469
Kapasiti Pasaran
1.94B
Nisbah P/E
-16.96
Pendapatan Dividen
-
Dividen
-
Akan Datang
Pendapatan
6NovDisahkan
EPS yang dijangka
-0.431434
EPS sebenar
N/A
Orang Lain Juga Mengikuti
Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti MIRM. Ini bukan cadangan pelaburan.
Peserta
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
Vertex Pharmaceuticals
VRTX
Kapasiti Pasaran120.91B
Alnylam Pharmaceuticals
ALNY
Kapasiti Pasaran34.6B
Gilead Sciences
GILD
Kapasiti Pasaran91.71B
Abbvie
ABBV
Kapasiti Pasaran335.48B
Pfizer
PFE
Kapasiti Pasaran161.78B
Novartis
NVS
Kapasiti Pasaran245.03B
Merck
MRK
Kapasiti Pasaran290.13B
Astrazeneca
AZN
Kapasiti Pasaran251.73B
Bristol-Myers Squibb
BMY
Kapasiti Pasaran94.72B
Penilaian Penganalisis
57.3$Sasaran Harga Purata
Anggaran tertinggi adalah $68.
Dari 10 penilaian dalam tempoh 6 bulan terakhir. Ini bukan cadangan pelaburan.
Beli
90%
Pegang
10%
Jual
0%
Mengenai
Health Technology
Pharmaceuticals: Major
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.
Show more...
CEO
Pekerja
294
Negara
US
ISIN
US6047491013
WKN
000A2PM29